For more than two decades, the global community has united to fight the HIV pandemic, achieving remarkable progress. New HIV transmissions and AIDS-related deaths have dropped significantly, and ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...

At the University of the Witwatersrand, scientists are developing HIV vaccines that could help change the course of the ...

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

The final, formatted version of the article will be published soon. Background: Moyamoya disease (MMD) is an idiopathic chronic intracranial vascular stenosis and occlusion disease However, there is ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Widespread use of contemporary antiretroviral therapy globally has transformed HIV disease into a chronic illness associated with excess risk for disorders of the heart and circulatory system. Current ...

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of ...